Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1980 Jul;10(1):23–32. doi: 10.1111/j.1365-2125.1980.tb00498.x

Studies on the clinical pharmacology of prazosin

I: cardiovascular, catecholamine and endocrine changes following a single dose

Peter C Rubin, Terrence F Blaschke
PMCID: PMC1430030  PMID: 6994759

Abstract

1 Cardiovascular, catecholamine and neuroendocrine changes were studied following administration of prazosin to ten normal subjects. In response to a fall in standing blood pressure from 87±5 (s.d.) mmHg to 49±20 (P < 0.01) heart rate (measured by continuous ECG monitoring) rose from 81±11 to 118±20 (P < 0.01). Five of the ten subjects sustained their tachycardia on standing and developed at most mild symptoms. In the other five, tachycardia suddenly gave way to bradycardia and they became syncopal.

2 In the supine position, when blood pressure was not significantly different from control, plasma noradrenaline concentration (nmol/l) was 2±0.5 compared with a control value of 1.2±0.3 (P < 0.01). In response to standing hypotension plasma noradrenaline was 4.2±2.7 compared with a standing control value of 1.9±0.4 (P < 0.02).

3 Four hours after taking prazosin five of the subjects stood for 30 min and blood was drawn for plasma renin activity (PRA). Blood pressure at this time was 15 mmHg below control (P < 0.02). PRA (ng ml-1 h-1) was 6.4±2.3 compared with time matched placebo control of 1.4±0.8 (P < 0.01).

4 At the same time as the PRA sampling, plasma cortisol was 15.6±2.6 μg/100 ml during hypotension and 8.2±3.9 following placebo (P < 0.01). Growth hormone was 1.4±0.3 ng/ml during hypotension and 1.0±0.2 following placebo (P < 0.01). Prolactin did not rise significantly during hypotension induced by prazosin.

5 Isoprenaline infusion produced the same change in heart rate during the time of maximum prazosin action as when given alone.

6 It is concluded that these observations are not in keeping with earlier reports that prazosin lowers blood pressure without producing a reflex increase in heart rate or renin release. Nor are these findings in keeping with current theories of the mechanism of action of prazosin which variously suggest that noradrenaline concentration should not increase, or that the heart is incapable of responding to an adrenergic stimulus in the presence of prazosin.

Full text

PDF
29

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Althuis T. H., Hess H. J. Synthesis and identification of the major metabolites of prazosin formed in dog and rat. J Med Chem. 1977 Jan;20(1):146–149. doi: 10.1021/jm00211a031. [DOI] [PubMed] [Google Scholar]
  2. Cambridge D., Davey M. J., Massingham R. Prazosin, a selective antagonist of post-synaptic alpha-adrenoceptors [proceedings]. Br J Pharmacol. 1977 Mar;59(3):514P–515P. [PMC free article] [PubMed] [Google Scholar]
  3. Cavero I., Lefèvre F., Roach A. G. Differential effects of prazosin on the pre- and postsynaptic alpha-adrenoceptors in the rat and dog [proceedings]. Br J Pharmacol. 1977 Nov;61(3):469P–469P. [PMC free article] [PubMed] [Google Scholar]
  4. Gawel M. J. Prolactin rise after a fall in blood-pressure. Lancet. 1977 Oct 15;2(8042):821–821. doi: 10.1016/s0140-6736(77)90754-1. [DOI] [PubMed] [Google Scholar]
  5. Graham R. M., Oates H. F., Stoker L. M., Stokes G. S. Alpha blocking action of the antihypertensive agent, prazosin. J Pharmacol Exp Ther. 1977 Jun;201(3):747–752. [PubMed] [Google Scholar]
  6. Graham R. M., Thornell I. R., Gain J. M., Bagnoli C., Oates H. F., Stokes G. S. Prazosin: the first-dose phenomenon. Br Med J. 1976 Nov 27;2(6047):1293–1294. doi: 10.1136/bmj.2.6047.1293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Harrison D. C., Fitzgerald J. W., Winkle R. A. Ambulatory electrocardiography for diagnosis and treatment of cardiac arrhythmias. N Engl J Med. 1976 Feb 12;294(7):373–380. doi: 10.1056/NEJM197602122940706. [DOI] [PubMed] [Google Scholar]
  8. Hess H. J. Prazosin: biochemistry and structure-activity studies. Postgrad Med. 1975 Nov;Spec No:9–17. [PubMed] [Google Scholar]
  9. Hsueh W. A., Luetscher J. A., Carlson E. J., Grislis G. Big renin in plasma of healthy subjects on high sodium intake. Lancet. 1978 Jun 17;1(8077):1281–1284. doi: 10.1016/s0140-6736(78)91267-9. [DOI] [PubMed] [Google Scholar]
  10. Hua A. S., Myers J. B., Kincaid-Smith P. Studies with prazosin--a new effective hypotensive agent. III. An acute double-blind cross-over study comparing the effects of single doses of prazosin and hydrallazine in combination with propranolol and a diuretic. Med J Aust. 1978 Jan 14;1(1):45–48. [PubMed] [Google Scholar]
  11. Jaillon P., Rubin P., Yee Y. G., Ball R., Kates R., Harrison D., Blaschke T. Influence of congestive heart failure on prazosin kinetics. Clin Pharmacol Ther. 1979 Jun;25(6):790–794. doi: 10.1002/cpt1979256790. [DOI] [PubMed] [Google Scholar]
  12. Komarek J., Cartheuser C. F. Dihydralazin versus Prazosin. Der hämodynamische Effekt der Modellsubstanzen. Z Kardiol. 1977 Dec;66(12):706–711. [PubMed] [Google Scholar]
  13. Koshy M. C., Mickley D., Bourgiognie J., Blaufox M. D. Physiologic evaluation of a new antihypertensive agent: prazosin HCl. Circulation. 1977 Mar;55(3):533–537. doi: 10.1161/01.cir.55.3.533. [DOI] [PubMed] [Google Scholar]
  14. Langer S. Z. Sixth gaddum memorial lecture, National Institute for Medical Research, Mill Hill, January 1977. Presynaptic receptors and their role in the regulation of transmitter release. Br J Pharmacol. 1977 Aug;60(4):481–497. doi: 10.1111/j.1476-5381.1977.tb07526.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Massingham R., Hayden M. L. A comparsion of the effects of prazosin and hydrallazine on blood pressure, heart rate and plasma renin activity in conscious renal hypertensive dogs. Eur J Pharmacol. 1975 Jan;30(1):121–124. doi: 10.1016/0014-2999(75)90213-7. [DOI] [PubMed] [Google Scholar]
  16. Nisticó G., Trimarchi F., Consolo F. Prolactin rise after fall in blood-pressure. Lancet. 1977 Dec 24;2(8052-8053):1364–1365. doi: 10.1016/s0140-6736(77)90422-6. [DOI] [PubMed] [Google Scholar]
  17. Noel G. L., Suh H. K., Stone J. G., Frantz A. G. Human prolactin and growth hormone release during surgery and other conditions of stress. J Clin Endocrinol Metab. 1972 Dec;35(6):840–851. doi: 10.1210/jcem-35-6-840. [DOI] [PubMed] [Google Scholar]
  18. Peuler J. D., Johnson G. A. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci. 1977 Sep 1;21(5):625–636. doi: 10.1016/0024-3205(77)90070-4. [DOI] [PubMed] [Google Scholar]
  19. Rosendorff C. Prazosin: severe side effects are dose-dependent. Br Med J. 1976 Aug 28;2(6034):508–508. doi: 10.1136/bmj.2.6034.508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Scriabine A., Constantine J. W., Hess H. J., McShane W. K. Pharmacological studies with some new antihypertensive aminoquinazolines. Experientia. 1968 Nov 15;24(11):1150–1151. doi: 10.1007/BF02147820. [DOI] [PubMed] [Google Scholar]
  21. Stokes G. S., Graham R. M., Gain J. M., Davis P. R. Influence of dosage and dietary sodium on the first-dose effects of prazosin. Br Med J. 1977 Jun 11;1(6075):1507–1508. doi: 10.1136/bmj.1.6075.1507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Taylor J. A., Twomey T. M., von Wittenau M. S. The metabolic fate of prazosin. Xenobiotica. 1977 Jun;7(6):357–364. doi: 10.3109/00498257709035794. [DOI] [PubMed] [Google Scholar]
  23. Turner A. S., Watson O. F., Brocklehurst J. E. Prazosin in hypertension. Part I. Clinical experience in 100 patients. N Z Med J. 1977 Sep 28;86(596):282–285. [PubMed] [Google Scholar]
  24. WEISSLER A. M., WARREN J. V., ESTES E. H., Jr, MCINTOSH H. D., LEONARD J. J. Vasodepressor syncope; factors influencing cardiac output. Circulation. 1957 Jun;15(6):875–882. doi: 10.1161/01.cir.15.6.875. [DOI] [PubMed] [Google Scholar]
  25. Wood A. J., Bolli P., Simpson F. O. Prazosin in normal subjects: plasma levels, blood pressure and heart rate. Br J Clin Pharmacol. 1976 Feb;3(1):199–201. doi: 10.1111/j.1365-2125.1976.tb00592.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Yee Y. G., Rubin P. C., Meffin P. Prazosin determination by high-pressure liquid chromatography using fluorescence detection. J Chromatogr. 1979 Apr 21;172:313–318. doi: 10.1016/s0021-9673(00)90967-1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES